ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

ClinicalTrials.gov ID: NCT01937130

Public ClinicalTrials.gov record NCT01937130. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Placebo-Controlled, Multicenter, Double-Blind, Randomized, Pharmacokinetic and Pharmacodynamic Trial of IDN-6556 in Subjects With Acute-on-Chronic Liver Failure

Study identification

NCT ID
NCT01937130
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Conatus Pharmaceuticals Inc.
Industry
Enrollment
23 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2013
Primary completion
Dec 31, 2014
Completion
Jan 31, 2015
Last update posted
Apr 10, 2016

2013 – 2015

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Scripps Clinic La Jolla California 92037
VA San Diego Healthcare System San Diego California 92161
Sutter Pacific Medical Foundation San Francisco California 94115
Georgetown University Hospital Washington D.C. District of Columbia 20007
University of Kansas Medical Center Kansas City Kansas 66160
Univerisity of Louisville Liver Research Center Louisville Kentucky 40202
University of Mississippi Medical Center Jackson Mississippi 39216
Montefiore Medical Center The Bronx New York 10467
University of Utah Salt Lake City Utah 84132
University of Washington Harborview Medical Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01937130, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 10, 2016 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01937130 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →